Valeant Pharmaceuticals International Inc (NYSE:VRX)

238.77
Delayed Data
As of May 29
 -2.96 / -1.22%
Today’s Change
106.00
Today|||52-Week Range
246.01
+66.84%
Year-to-Date

Today’s Trading

Previous close241.73
Today’s open240.36
Day’s range236.50 - 241.70
Volume1,395,498
Average volume (3 months)2,236,739
Market cap$82.4B
Dividend yield--
Data as of 4:07pm ET, 05/29/2015

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+32.91%
Earnings growth (next 5 years)+17.50%
Revenue growth (last year)+43.22%
P/E ratio89.3
Price/Sales5.83
Price/Book15.22

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+2.49+3.26%
AZNAstraZeneca-1.35-1.96%
CELGCelgene-0.49-0.43%
ABTAbbott Laboratories-0.66-1.34%
Data as of 4:05pm ET, 05/29/2015

Financials

Next reporting dateJuly 30, 2015
EPS forecast (this quarter)$2.44
Annual revenue (last year)$8.3B
Annual profit (last year)$913.5M
Net profit margin11.05%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chairman &
Chief Executive Officer
J. Michael Pearson
Chief Financial Officer, Director &
Executive VP
Howard Bradley Schiller
Corporate headquarters
Laval, Quebec

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers